Significant Ownership of Paul B. Manning
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Paul B. Manning focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Paul B. Manning - Paul B. Manning
- Manager location
- Charlottesville, VA
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Paul B. Manning and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from Paul B. Manning
Significant Ownership of Paul B. Manning
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| VRCA | Verrica Pharmaceuticals Inc. | Common Stock, $0.0001 par value per share | 50% | $28,437,789 | 8,056,031 | Paul B Manning | 25 Nov 2025 | ||
| TSHA | TAYSHA GENE THERAPIES, INC. | Common Stock, $0.00001 par value per share | 9.8% | $59,394,578 | 25,601,111 | Paul B Manning | 30 May 2025 | ||
| CADL | CANDEL THERAPEUTICS, INC. | Common Stock, $0.01 par value per share | 7.9% | $29,997,375 | 5,790,999 | Paul B Manning | 16 Dec 2024 |
Schedules 13D/G Reported by Paul B. Manning:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.